journal of thoracic oncology سال:2018 - دوره:13

Fa | Ar | En


journal of thoracic oncology
سال:2018 - دوره:13 - شماره:1

a cascade of pembrolizumab-induced autoimmune toxicities with mixed responses to corticosteroids - صفحه:e8-e9 acquired resistance to afatinib due to t790m-positive squamous progression in egfr-mutant adenosquamous lung carcinoma - صفحه:e9-e12 baseline and on-treatment characteristics of serum tumor markers in stage iv oncogene-addicted adenocarcinoma of the lung - صفحه:134-138 brms1 expression in surgically resected lung adenocarcinoma predicts future metastases and is associated with a poor prognosis - صفحه:73-84 cell-free dna analysis in sclc: ready for clinical practice? - صفحه:10-11 chimeric antigen receptor (car) t-cell therapy for thoracic malignancies - صفحه:16-26 clinical and translational implications of ret rearrangements in non–small cell lung cancer - صفحه:27-45 comorbidity in lung cancer: a prospective cohort study of self-reported versus register-based comorbidity - صفحه:54-62 ct screening for lung cancer: successful trial, but failed understanding - صفحه:12-15 evaluation of ret gene rearrangement by fluorescence in situ hybridization in malignant mesothelioma - صفحه:e12-e14 first-line osimertinib in patients with treatment-naive somatic or germline egfr t790m–mutant metastatic nsclc - صفحه:e3-e5 four-year complete remission in a patient with metastatic epidermal growth factor receptor–mutated lung cancer treated with two cycles of erlotinib - صفحه:e7-e8 genetic and immune profiles of solid predominant lung adenocarcinoma reveal potential immunotherapeutic strategies - صفحه:85-96 increased response rates to salvage chemotherapy administered after pd-1/pd-l1 inhibitors in patients with non–small cell lung cancer - صفحه:106-111 longitudinal cell-free dna analysis in patients with small cell lung cancer reveals dynamic insights into treatment efficacy and disease relapse - صفحه:112-123 molecular adequacy of image-guided rebiopsies for molecular retesting in advanced non–small cell lung cancer: a single-center experience - صفحه:63-72 molecular and histopathological characterization of the tumor immune microenvironment in advanced stage of malignant pleural mesothelioma - صفحه:124-133 obesity paradox in lung cancer prognosis: is mir-26b the achilles heel? - صفحه:e15- peripheral blood biomarkers associated with clinical outcome in non–small cell lung cancer patients treated with nivolumab - صفحه:97-105 pseudoprogression associated with clinical deterioration and worsening quality of life in malignant pleural mesothelioma - صفحه:e1-e2 regression of paraneoplastic rash after lung cancer chemotherapy - صفحه:139-140 reply to “obesity paradox in lung cancer prognosis: is mir-26b the achilles heel?” - صفحه:e16- risk of second lung cancer in patients with previously treated lung cancer: analysis of surveillance, epidemiology, and end results (seer) data - صفحه:46-53